VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms. Am J Hematol. 2018 02; 93(2):277-285.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Anemia
Azacitidine
Drug Administration Schedule
Drug Therapy, Combination
Female
Humans
Male
Middle Aged
Myelodysplastic-Myeloproliferative Diseases
Nitriles
Pyrazoles
Pyrimidines
Survival Analysis
Thrombocytopenia
Treatment Outcome
authors with profiles
CARLOS E BUESO-RAMOS
RAJYALAKSHMI LUTHRA
ZEEV ESTROV
JORGE E CORTES
SRDAN VERSTOVSEK
GUILLERMO GARCIA-MANERO
ELIAS JOSEPH JABBOUR
GAUTAM BORTHAKUR
TAPAN MAHENDRA KADIA
NAVEEN PEMMARAJU
NAVAL DAVER
COURTNEY DINARDO
PRITHVIRAJ BOSE
HAGOP M KANTARJIAN